Welcome to our dedicated page for VirnetX Holding SEC filings (Ticker: VHC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on VirnetX Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into VirnetX Holding's regulatory disclosures and financial reporting.
VirnetX Holding Corp (VHC) reports that its President & CEO and ten percent owner, Kendall Larsen, sold a total of 14,575 shares of common stock in open-market transactions on August 31, 2026, September 1, 2026, and September 2, 2026, under a Rule 10b5-1 trading plan adopted on May 29, 2026. Indirect holdings reported as of August 31, 2026, include 74,649 shares held by a spouse, 30,676 shares held by the Kathleen Sheehan Revocable Trust, and 15,000 shares held by The K2 Investment Fund LLC.
VirnetX Holding Corp (VHC) director Gary Feiner reported open-market sales of an aggregate 7,500 shares of common stock in late August and early September 2026. The trades were effected under a Rule 10b5-1 trading plan adopted on May 29, 2026, with prices reported on a weighted-average basis within disclosed ranges.
VirnetX Holding Corp (VHC) received a Rule 144 notice from officer Kendall Larsen covering a proposed sale of 35,000 shares of common stock through Apex Clearing. The shares, acquired on 04/01/2009 via restricted stock vesting and stock option exercise, have an aggregate market value of $477,050, with 4,216,633 shares of common stock outstanding and an intended sale no later than 08/31/2026.
VirnetX Holding Corp (VHC) received a Rule 144 notice from director Gary Feiner covering a potential future sale of company stock. The filing references 7,500 shares of common stock, related to restricted stock vesting, with an approximate sale date of August 31, 2026 through broker Apex Clearing.
VirnetX Holding Corporation reported continued operating losses and liquidity pressure for the quarter ended June 30, 2026. Revenue was $0 for both the three- and six-month periods, compared with $48,000 a year earlier, while operating expenses rose to $4.7 million in the quarter, driven mainly by higher selling, general and administrative costs.
Net loss was $4.5 million for the quarter and $8.9 million for the first half of 2026, increasing from $7.3 million in the prior-year six-month period. Cash and cash equivalents fell to $13.1 million from $15.5 million at year-end, with $7.6 million used in operating activities in the first half.
Total assets were $23.0 million and shareholders’ equity $15.1 million, against total liabilities of $7.9 million. Management concluded that existing liquidity is insufficient to fund operations for 12 months without additional revenue or capital, leading to a going concern warning. The company highlights a $20 million effective shelf registration and continues to focus on commercializing its VirnetX One™, Matrix™, War Room™ and iSCOUT cybersecurity platforms, particularly for U.S. defense, government and critical infrastructure customers.
VirnetX Holding Corp Chief Financial Officer Katherine Allanson reported a routine tax-related share disposition. On July 6, 2026, 100 shares of common stock were withheld by the company at $11.95 per share to satisfy income tax and withholding obligations tied to previously reported restricted stock awards. The footnote clarifies this withholding does not represent an open-market sale by Allanson. Following the transaction, she directly holds 31,205 shares of VirnetX common stock.
O'BRIEN THOMAS M reported acquisition or exercise transactions in this Form 4 filing.
VirnetX Holding Corp director Thomas M. O'Brien received a grant of 7,500 shares of restricted common stock on June 11, 2026 as equity compensation. The award carries no purchase price and increases his direct holdings to 35,457 shares.
The restricted shares vest in full on the earlier of the one-year anniversary of the grant date or the close of business on the day before VirnetX's 2027 annual stockholder meeting, provided he remains a service provider through that date. If a Change in Control occurs before then, any unvested restricted shares will vest immediately before the transaction closes.
VirnetX Holding Corporation reported the results of its 2026 annual meeting of stockholders. Stockholders approved an amendment to the Amended and Restated 2013 Equity Incentive Plan, increasing the number of shares of common stock reserved for issuance under the plan by 1,000,000 shares.
Two Class I directors, Kendall Larsen and Gary W. Feiner, were elected to serve until the 2029 annual meeting. Stockholders ratified the appointment of Farber Hass Hurley LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved, on an advisory basis, the compensation of the company’s named executive officers. A quorum was present, with 2,639,678 shares represented, equal to 63.06% of the voting power as of the April 16, 2026 record date.
Angelo Michael F reported acquisition or exercise transactions in this Form 4 filing.
VirnetX Holding Corp director Michael F. Angelo received a grant of 7,500 shares of restricted common stock. The award was granted at no cash cost per share and increases his direct holdings to 29,209 shares. The restricted shares will vest in full on the earlier of the one-year anniversary of the grant date or the day before VirnetX’s 2027 annual stockholders’ meeting, provided he remains a service provider. Any unvested restricted shares will fully vest immediately before a qualifying change in control of the company.
Chow Heidy Kingwan reported acquisition or exercise transactions in this Form 4 filing.
VirnetX Holding Corp director Heidy Kingwan Chow received a grant of 7,500 shares of common stock as restricted stock on June 11, 2026. The shares were granted at no purchase price and increase her direct holdings to 37,500 shares.
The restricted stock will fully vest on the earlier of the one-year anniversary of the grant date or the close of business on the day prior to VirnetX’s 2027 annual meeting of stockholders, subject to her continued service. Any unvested shares will vest immediately before a Change in Control transaction.